ea0094p287 | Thyroid | SFEBES2023
Lewin Michelle
, Grounds Kerrie
, Hamilton Amanda
, Jones Karen
, Panicker Janki
Background: Thyroid stimulating receptor hormone receptor antibodies (TRAb) markers are useful in confirming diagnosis of Graves disease, but also recognised as a predictor of relapse. Good practice dictates that a TRAb is measured at the commencement of treatment, to confirm a diagnosis of graves disease. Repeating the TRAb before discontinuation of treatment can assist in guiding treatment. If TRAb remains elevated, the chances of relapse are inc...